![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1660-2862|15|3|188-190
ISSN: 1660-2854
Source: Neurodegenerative Diseases, Vol.15, Iss.3, 2015-06, pp. : 188-190
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anticholinergic Activity and Alzheimer's Disease
Neurodegenerative Diseases, Vol. 15, Iss. 3, 2015-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants
Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease
Neurodegenerative Diseases, Vol. 15, Iss. 3, 2015-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Plasma Homocysteine and Risk of Coexisting Silent Brain Infarction in Alzheimer’s Disease
Neurodegenerative Diseases, Vol. 2, Iss. 6, 2006-05 ,pp. :